SAVIOR LIFETEC CORPORATION |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 23 TWD | +0.66% |
|
+7.73% | +2.45% |
ETFs positioned on Savior Lifetec Corporation
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.00% | 34 M€ | +3.53% | - |
SAVIOR LIFETEC CORPORATION is a Taiwan-based company principally engaged in the development, manufacture and distribution of antibiotic bulk pharmaceutical chemicals and intermediates. The Companyâs products portfolio mainly consists of Meropenem and Imipenem/Cilastatin, Meropenem as well as Ertapenem, among others, which are used as spectrum antibiotics. In addition, it is involved in the provision of APIs intermediates as well as bio-pharmaceutical technology services. The Company distributes its products to Europe, the Americas, Asia and other markets.
Sector
Pharmaceuticals
| 1st Jan change | Capi. | |
|---|---|---|
| +2.45% | 226M | |
| +21.28% | 44.4B | |
| +24.60% | 23.03B | |
| +18.51% | 15.14B | |
| +12.87% | 13.12B | |
| +44.67% | 11.85B | |
| -8.33% | 6.99B | |
| -0.05% | 6.79B | |
| -8.87% | 5.73B | |
| +12.22% | 5.52B |
- Stock Market
- Equities
- 4167 Stock
- Funds and ETFs Savior Lifetec Corporation